LTRYW
Translational Development Acquisition Corp.
NASDAQ · Consumer Cyclical · Gambling, Resorts & Casinos · US
$0.00
−5.26%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.00
From 52W high−77.78%
Volume1438.00
Market cap$13422.77
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataSep 18, 2026
Open
$0.00
From 52W high
−77.78%
Volume
1438.00
Market cap
$13422.77
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
P/E (TTM)
—
RSI (14)
39.1
MomentumView details →
1D Return
−5.26%
YTD Return
−17.65%
Similar companies
Latest newsMore news →
ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.54d agoTranslational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.76d ago